William Blair lowered their Q3 2025 EPS estimates for ResMed in a research report issued on Monday, February 3rd. William Blair analyst M. Andrew now anticipates that the medical equipment provider ...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also ...

Passive income investors looking to grab the record-high ResMed Inc (ASX: RMD) dividend will need to act soon. Here’s what’s ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

The ResMed share price is having a tough start to the week. Is this a buying opportunity for investors? Let's find ...

Chicago Partners Investment Group LLC acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the 4th ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) just unveiled an update. ResMed Inc. has ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

The maker of sleep devices, Kiwi-based Fisher & Paykel Healthcare expects a Trump tariff hit because it manufactures in ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

The recipe to most happy investing outcomes is painfully simple. But if it were that easy, wouldn't everybody do it?